About Contact Us Careers

Leucovorin Calcium Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 4020
Published Date: Dec 20, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Leucovorin Calcium Landscape

Exelixis Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
PromoCell GmbH
Thermo Fisher Scientific Inc.
Boehringer Ingelheim GmbH
Bayer AG
Abbott Laboratories
Merck & Co., Inc.
Mylan N.V.
Novartis International AG
Pfizer Inc.

Browse Key Market Insights with Data Illustration:

Leucovorin Calcium Market Size, Growth Forecasts 2037

In the News

Exelixis Inc. announced the successful results for Cabozantinib in combination with immunotherapies in patients with advanced colorectal cancer.
PromoCell GmbH to lead research on immunotherapies through all human primary cells and blood & stem cells, including MHC class I genes HLA-A, -B, and -C.

Author Credits: Radhika Pawar

Report ID: 4020
Published Date: Dec 20, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of leucovorin calcium is estimated at USD 34.38 million.

The leucovorin calcium market size was over USD 26.98 million in 2024 and is poised to exceed USD 187.87 million by 2037, witnessing over 16.1% CAGR during the forecast period i.e., between 2025-2037. The increasing prevalence of colorectal cancer and rising cancer awareness will propel the market growth.

North America industry is set to hold largest revenue share by 2037, owing to presence of major pharmaceutical companies in the region.

The major players in the market are Exelixis Inc., PromoCell GmbH, Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Bayer AG, Abbott Laboratories, Merck & Co., Inc., Mylan N.V., Novartis International AG, Pfizer Inc.

Inquiry Before Buying Request Free Sample